v3.26.1
Equity - Narratives (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 01, 2026
Feb. 02, 2026
Jul. 03, 2026
Jul. 03, 2026
Jul. 01, 2026
Jun. 10, 2026
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Preferred stock, par value (in dollars per share)     $ 0.001 $ 0.001    
Cumulative dividends, annually       6.50%    
Cumulative dividends, annually (in dollars per share)       $ 65.00    
Cash dividends, maximum (in dollars per share)     0.10      
Board of Directors Chairman            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Preferred Stock Purchased, Amount $ 100.0          
Steven Rale            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Preferred Stock Purchased, Amount 25.0          
Other Third Party            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Preferred Stock Purchased, Amount $ 50.0          
Mandatory Convertible Preferred Stock            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Stock price (in dollars per share) $ 1,000          
Preferred stock, par value (in dollars per share) $ 0.001          
Sale of Stock, Consideration Received on Transaction $ 171.1          
Stock issuance costs $ 3.9          
Contractual interest rate 6.50%          
Preferred Stock            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Stock price (in dollars per share)     $ 114.00 $ 114.00    
Stock issuance costs $ 175.0          
Number of shares sold (in shares) 175,000          
Preferred Stock | Minimum            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Shares issued (in shares)       1,256,605    
Preferred Stock | Maximum            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Shares issued (in shares)       1,445,080    
Common Stock            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Sale of Stock, Consideration Received on Transaction $ 139.8          
Stock issuance costs $ 3.2 $ 143.0        
Number of shares sold (in shares) 1,254,255          
Common Stock | Minimum            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Shares issued (in shares)       7.1806    
Common Stock | Maximum            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Shares issued (in shares)       8.2576    
Performance-Based Stock Option Awards            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Weighted average grant date fair value, per share (in dollars per share)       $ 26.90    
Aggregate grant-date fair value     $ 64.4 $ 64.4    
Stock based compensation expense     0.7 0.7    
Unrecognized compensation cost     $ 63.7 $ 63.7    
Risk-free interest rate(2)       4.40%    
Expected dividend yield       0.60%    
Performance-Based Stock Option Awards | Tranche One            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Stock price (in dollars per share)     $ 140.00 $ 140.00    
Performance-Based Stock Option Awards | Tranche Two            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Stock price (in dollars per share)     170.00 170.00    
Performance-Based Stock Option Awards | Tranche Three            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Stock price (in dollars per share)     $ 200.00 $ 200.00    
Amended and Restated 2022 Omnibus Incentive Plan | Performance-Based Stock Option Awards            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Options outstanding (in shares)     2,394,496 2,394,496 58,056 2,336,440
Awards, exercise price (in dollars per share)         $ 93.69 $ 82.92